loader
Please Wait
Applying Filters...
menu
    • menu

    Product Under Development 2025 services provided by Synnat Pharma

    Virtual BoothMenuSynnat Pharma
    Product Under Development 2025

    PDF Upload May, 2025
    News
    Strides Acquires Sandoz Generic Brands to Boost Africa Business

    18 Mar 2026

    // PRESS RELEASE

    FDA Rejects Aldeyra Eye Disease Candidate for 3rd Time

    18 Mar 2026

    // FIERCE BIOTECH

    Pfizer’s Ibrance Heir Reduces Risk of Death in Ph 2 Breast Cancer

    18 Mar 2026

    // BIOSPACE

    DATA COMPILATION
    #PharmaFlow

    Synnat VB RM

    Contact Supplier

    Website

    Food Ingredients China

    Not Confirmed

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    radio-compass-blog/fda-approvals-drop-8-in-2025-with-fewer-blockbusters-brinsupri-rhapsido-make-it-to-first-in-class-list
    Xls

    CATEGORY PAGE
    Menu

    Synnat Pharma

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    Key Products KEY PRODUCTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    PI70279
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.